berberine has been researched along with Weight Gain in 14 studies
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study suggests that berberine is a potential weight loss and weight maintenance drug for patients with schizophrenia." | 9.51 | Berberine treatment for weight gain in patients with schizophrenia by regulating leptin rather than adiponectin. ( Jia, Q; Li, J; Li, M; Liu, Y; Qiu, Y; Zhang, J; Zhang, Y; Zhao, Y, 2022) |
| "The aim of this study was to evaluate the efficacy and safety of berberine as an adjuvant in treating antipsychotic-associated weight gain and metabolic syndrome." | 9.51 | Adjunctive berberine reduces antipsychotic-associated weight gain and metabolic syndrome in patients with schizophrenia: a randomized controlled trial. ( Chan, M; Chen, EYH; Feng, Y; Han, F; Lai, WH; Lam, M; Lee, CK; Lee, EHM; Liu, L; Man, SC; Ng, RMK; Qin, Z; Wong, HK; Wong, TL; Zhang, ZJ, 2022) |
| "To elucidate the protective effect of berberine on olanzapine induced-metabolic syndrome." | 7.91 | Berberine attenuates olanzapine induced-metabolic syndrome. ( Al-Gareeb, AI; Al-Kuraishy, HM; Al-Naimi, MS; Rasheed, HA, 2019) |
| "Olanzapine is a first line medication for the treatment of schizophrenia, but it is also one of the atypical antipsychotics carrying the highest risk of weight gain." | 7.80 | Metformin and berberine prevent olanzapine-induced weight gain in rats. ( Davies, GE; Davies, PS; Droke, EA; Ehli, EA; Hu, Y; Nowotny, D; Soundy, TJ; Young, AJ, 2014) |
| "This study suggests that berberine is a potential weight loss and weight maintenance drug for patients with schizophrenia." | 5.51 | Berberine treatment for weight gain in patients with schizophrenia by regulating leptin rather than adiponectin. ( Jia, Q; Li, J; Li, M; Liu, Y; Qiu, Y; Zhang, J; Zhang, Y; Zhao, Y, 2022) |
| "The aim of this study was to evaluate the efficacy and safety of berberine as an adjuvant in treating antipsychotic-associated weight gain and metabolic syndrome." | 5.51 | Adjunctive berberine reduces antipsychotic-associated weight gain and metabolic syndrome in patients with schizophrenia: a randomized controlled trial. ( Chan, M; Chen, EYH; Feng, Y; Han, F; Lai, WH; Lam, M; Lee, CK; Lee, EHM; Liu, L; Man, SC; Ng, RMK; Qin, Z; Wong, HK; Wong, TL; Zhang, ZJ, 2022) |
| "Nonalcoholic fatty liver disease (NAFLD) is considered a critical hepatic manifestation of metabolic syndrome." | 5.46 | Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease. ( Cang, Z; Lu, Y; Nie, X; Sun, H; Wang, N; Zhao, L, 2017) |
| "To elucidate the protective effect of berberine on olanzapine induced-metabolic syndrome." | 3.91 | Berberine attenuates olanzapine induced-metabolic syndrome. ( Al-Gareeb, AI; Al-Kuraishy, HM; Al-Naimi, MS; Rasheed, HA, 2019) |
| "Berberine could reduce weight gain and lipolysis in the high-fat diet-fed group." | 3.83 | Modulation of Microbiota-Gut-Brain Axis by Berberine Resulting in Improved Metabolic Status in High-Fat Diet-Fed Rats. ( Cang, Z; Cheng, J; Lu, Y; Nie, X; Sun, H; Wang, N; Xia, F; Zhai, H; Zhao, L; Zhu, C, 2016) |
| "Epiberberine was found to be associated with the inhibition of weight gain." | 1.72 | Toxicity and toxicokinetics of the ethanol extract of Zuojin formula. ( Gao, Y; Li, L; Li, Y; Liu, X; Shan, D; Wang, Q; Wang, S; Yang, Z; Zhang, T; Zhang, Y, 2022) |
| "Berberine has been reported to have pharmacological activity in adipose tissue to anti-obesity, while the mechanism remains unclear." | 1.62 | Berberine modulates deacetylation of PPARγ to promote adipose tissue remodeling and thermogenesis via AMPK/SIRT1 pathway. ( Cao, L; He, Z; Jiang, X; Kong, J; Li, N; Ma, G; Song, X; Wang, Z; Wen, D; Xu, Y; Yang, F; Yu, T; Yu, Y; Zheng, L, 2021) |
| "Nonalcoholic fatty liver disease (NAFLD) is considered a critical hepatic manifestation of metabolic syndrome." | 1.46 | Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease. ( Cang, Z; Lu, Y; Nie, X; Sun, H; Wang, N; Zhao, L, 2017) |
| " lycium extracts as well as berberine were not lethal up to dosage of 2000 mg/kg body weight." | 1.40 | In vivo anticoccidial activity of berberine [18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium]--an isoquinoline alkaloid present in the root bark of Berberis lycium. ( Ahad, S; Chishti, MZ; Johri, RK; Kamili, AN; Malik, TA; Tanveer, S, 2014) |
| "Berberine treatments were either provided in preventive or therapeutic mode respectively." | 1.39 | Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study. ( Chitra, P; Manikandan, R; Saiprasad, G; Sudhandiran, G, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| Qiu, Y | 1 |
| Li, M | 2 |
| Zhang, Y | 3 |
| Liu, Y | 1 |
| Zhao, Y | 2 |
| Zhang, J | 2 |
| Jia, Q | 1 |
| Li, J | 1 |
| Chan, M | 1 |
| Qin, Z | 1 |
| Man, SC | 1 |
| Lam, M | 1 |
| Lai, WH | 1 |
| Ng, RMK | 1 |
| Lee, CK | 1 |
| Wong, TL | 1 |
| Lee, EHM | 1 |
| Wong, HK | 1 |
| Feng, Y | 1 |
| Liu, L | 1 |
| Han, F | 1 |
| Chen, EYH | 1 |
| Zhang, ZJ | 1 |
| Wang, S | 1 |
| Zhang, T | 1 |
| Liu, X | 1 |
| Yang, Z | 1 |
| Li, L | 1 |
| Shan, D | 1 |
| Gao, Y | 1 |
| Li, Y | 2 |
| Wang, Q | 1 |
| Urasaki, Y | 1 |
| Le, TT | 1 |
| Al-Naimi, MS | 1 |
| Rasheed, HA | 1 |
| Al-Kuraishy, HM | 1 |
| Al-Gareeb, AI | 1 |
| Xu, Y | 1 |
| Yu, T | 1 |
| Ma, G | 1 |
| Zheng, L | 1 |
| Jiang, X | 1 |
| Yang, F | 1 |
| Wang, Z | 1 |
| Li, N | 1 |
| He, Z | 1 |
| Song, X | 1 |
| Wen, D | 1 |
| Kong, J | 1 |
| Yu, Y | 1 |
| Cao, L | 1 |
| Chitra, P | 1 |
| Saiprasad, G | 1 |
| Manikandan, R | 1 |
| Sudhandiran, G | 1 |
| Malik, TA | 1 |
| Kamili, AN | 1 |
| Chishti, MZ | 1 |
| Tanveer, S | 1 |
| Ahad, S | 1 |
| Johri, RK | 1 |
| Hu, Y | 2 |
| Young, AJ | 1 |
| Ehli, EA | 1 |
| Nowotny, D | 1 |
| Davies, PS | 1 |
| Droke, EA | 1 |
| Soundy, TJ | 1 |
| Davies, GE | 2 |
| Sun, H | 2 |
| Wang, N | 2 |
| Cang, Z | 2 |
| Zhu, C | 1 |
| Zhao, L | 3 |
| Nie, X | 2 |
| Cheng, J | 1 |
| Xia, F | 1 |
| Zhai, H | 1 |
| Lu, Y | 2 |
| Zhao, X | 1 |
| Tong, N | 1 |
| Liao, X | 1 |
| Wang, E | 1 |
| Li, Z | 1 |
| Luo, Y | 1 |
| Zuo, H | 1 |
| Zhang, X | 1 |
| Zhang, M | 1 |
| Pang, X | 1 |
| Xu, J | 1 |
| Kang, C | 1 |
| Zhang, C | 1 |
| Zhang, Z | 1 |
| Li, X | 1 |
| Ning, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Double-blind, Randomized, Placebo-controlled Trial of Berberine as an Adjuvant to Treat Antipsychotic-induced Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders[NCT02983188] | Phase 2/Phase 3 | 113 participants (Actual) | Interventional | 2018-04-25 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for berberine and Weight Gain
| Article | Year |
|---|---|
Berberine treatment for weight gain in patients with schizophrenia by regulating leptin rather than adiponectin.
Topics: Adiponectin; Antipsychotic Agents; Berberine; Body Mass Index; Double-Blind Method; Humans; Leptin; | 2022 |
Adjunctive berberine reduces antipsychotic-associated weight gain and metabolic syndrome in patients with schizophrenia: a randomized controlled trial.
Topics: Antipsychotic Agents; Berberine; Double-Blind Method; Humans; Metabolic Syndrome; Schizophrenia; Wei | 2022 |
12 other studies available for berberine and Weight Gain
| Article | Year |
|---|---|
Toxicity and toxicokinetics of the ethanol extract of Zuojin formula.
Topics: Alkaloids; Animals; Berberine; Body Weight; Coptis; Drugs, Chinese Herbal; Ethanol; Female; Male; Ra | 2022 |
A Composition of Phytonutrients for Glycemic and Weight Management.
Topics: Acrolein; Animals; Berberine; Blood Glucose; Curcumin; Diabetes Mellitus; Disease Models, Animal; Fa | 2022 |
Berberine attenuates olanzapine induced-metabolic syndrome.
Topics: Animals; Berberine; Biomarkers; Insulin Resistance; Male; Metabolic Syndrome; Olanzapine; Prospectiv | 2019 |
Berberine modulates deacetylation of PPARγ to promote adipose tissue remodeling and thermogenesis via AMPK/SIRT1 pathway.
Topics: Adipose Tissue, Brown; AMP-Activated Protein Kinases; Animals; Berberine; Blotting, Western; Body We | 2021 |
Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study.
Topics: Animals; Antimetabolites; Berberine; Bleomycin; Blotting, Western; Bronchoalveolar Lavage Fluid; Col | 2013 |
In vivo anticoccidial activity of berberine [18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium]--an isoquinoline alkaloid present in the root bark of Berberis lycium.
Topics: Animals; Berberine; Berberis; Chickens; Coccidiosis; Coccidiostats; Male; Parasite Egg Count; Phytot | 2014 |
Metformin and berberine prevent olanzapine-induced weight gain in rats.
Topics: Adipose Tissue, White; Animals; Antipyretics; Benzodiazepines; Berberine; Eating; Female; Ion Channe | 2014 |
Modulation of Microbiota-Gut-Brain Axis by Berberine Resulting in Improved Metabolic Status in High-Fat Diet-Fed Rats.
Topics: Animals; Berberine; Brain; Diet, High-Fat; Energy Metabolism; Gastrointestinal Microbiome; Glucagon- | 2016 |
Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Berberine; Carbohydrate Metabolism; Diet, High-Fat | 2017 |
Berberine inhibits adipogenesis in high-fat diet-induced obesity mice.
Topics: 3T3-L1 Cells; Adipogenesis; Animals; Berberine; Blood Glucose; Cholesterol; Diet, Atherogenic; Dieta | 2010 |
Berberine attenuates doxorubicin-induced cardiotoxicity in mice.
Topics: Animals; Berberine; Cardiotonic Agents; Cardiotoxins; Doxorubicin; Electrocardiography; Female; L-La | 2011 |
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats.
Topics: Adiposity; Animals; Berberine; Diet, High-Fat; Fatty Acids, Volatile; Feces; Feeding Behavior; Gastr | 2012 |